tact case patient subsequently died of SARS.
We reported our finding to Dr. Klaus Stohr, World Health Organization (WHO) coordinator for the SARS program, after confirming that the virus was a coronavirus and that a specific antibody response against the infected cell line could be demonstrated in many SARS patients. After a heated debate, the strain was released, with coordination by the WHO, to the relevant research community. Each individual researcher requesting the strain signed a transfer agreement.
Still, we are as worried as is the panicstricken general public. The number of patients with cases of SARS has increased to 1400, one-quarter of whom are our colleagues. There is no place for complacency; we still do not understand this virus well, and no vaccine will be available in the near future. From the epidemiological point of view, we believe that the infection has been spreading from Guangzhou since January 2003. The condition seems to be under control in the hospital setting; there have not been many new cases of infection among health care workers since morestringent infection control procedures were implemented.
We are starting to see a second wave of patients who have had no direct contact with the index case patients or health care workers. This is still a high-risk situation. Although we have no health care workers who are ill at our facility, our team has seen infected staff at other hospitals. On the basis of the experience in Guangzhou, we modified the treatment regimen used for adult respiratory distress syndrome and bronchitis obliterans with organized pneumonia, and we are using high-dose steroid therapy along with broad-spectrum antimicrobial coverage to treat patients with severe lung damage. The preliminary impression (unofficial data) is that conditions improved in ∼15% of patients and deteriorated in ∼15% of patients after high-dose steroid therapy.
The increasing number of cases of SARS in the community and among our colleagues added pressure to find the cause of the disease. People questioned whether we were capable of handling this disaster. Then researchers in Hong Kong announced that they had isolated a paramyxovirus from their cluster of patients. They described a gene-segment sequence that has 98% homology with the known sequence of human metapneumovirus and claimed that this is the cause of SARS.
However, human metapneumovirus is not known to cause such severe progressive pneumonia with concomitant thrombocytopenia, lymphopenia, and disturbed liver function at the time of presentation. We pressed on with our studies. We performed transmission electron microscopy on a cell pellet and then negative stain electron microscopy on ultra-centrifuged cell culture supernatant. Transmission electron microscopy revealed beautiful viral particles in clusters inside the endoplasmic reticulum of infected cells. Negative stain electron microscopy revealed pleomorphic viral particles with petal-like projections. We now know that a coronavirus is causing SARS, and we can discuss what we should consider doing for these patients.-V. C. C. Cheng, M. Peiris, and K. Y. Yuen 
